discontinued

NB100-62893 RITUXIMAB antibody

See related secondary antibodies

Search for all "RITUXIMAB"

0.1 mg / €430.00

Quick Overview

Human anti RITUXIMAB 2842

NB100-62893

Product Description for RITUXIMAB

Human anti RITUXIMAB 2842.
Product is tested for Enzyme Immunoassay.

Properties for RITUXIMAB

Product Category Primary Antibodies
Quantity 0.1 mg
Applications E
Clonality Monoclonal
Clone 2842
Host Human
Shipping to Not USA/Canada
PDF datasheet View Datasheet
Manufacturer Novus Biologicals Inc.

Datasheet Extract

Immunogen
Immunogen:
Rituximab
Add. information Research Areas: Immunology
Application ELISA, This antibody is useful for ELISA, ELISA 1/100
Background Rituximab humanised monoclonal antibody is a therapeutic reagent directed against the human CD20 cell surface antigen. Rituximab is a therapeutic reagent directed against the human CD20 cell surface antigen. This antibody has been used to detect Rituximab bound to the surface of the Raji B cell line, however detection of Rituximab bound 'in vivo' to B CLL cells has not been demonstrated. It is possible that complement deposition on Rituximab opsonised cells inhibits binding of the anti-Rituximab antibody to cell bound Rituximab.
Concentration 0.1 mg/ml
Storage Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Format
Purification:
Affinity purified
Buffer System:
0.09% Sodium Azide
Purity:
Affinity purified
Specificity
Specificity:
NB100-62893 specifically recognises the Rituximab humanised monoclonal. Rituximab is a therapeutic reagent directed against the human CD20 cell surface antigen. NB100-62893 does not recognise other CD20 antibodies.

Accessory Products

  • LinkedIn